Siyajabula ukujoyina abaholi bemboni e-CPHI South East Asia 2025, okwenzeka kusukela ngoJulayi 16 kuya ku-18 e-MITEC e-Kuala Lumpur. Umcimbi uhlanganisa ama-square metres angu-15,000 futhi uzohlanganisa abantu abangaba ngu-400. Bangaphezu kuka-8,000 ochwepheshe okulindeleke ukuba bathamele, kanye namasemina nezithangami ezingama-60+ ezigxile enkambweni yamanje yezimboni, ubuchwepheshe obusha, nentuthuko yokulawula. Kuyithuba elihle kakhulu lokuxhumana nokusebenzisana kulo lonke uchungechunge lokuhlinzeka ngemithi.

Mayelana ne-JYMed
 
I-JYMed yinkampani yemithi ehamba phambili egxile kwi-peptide egxile kwezocwaningo, ukuthuthukiswa, ukukhiqiza, kanye nokuhweba. Sinikezela ngezinsizakalo ezihlanganiswe ngokuphelele ze-CDMO ezenzelwe amaklayenti emithi, izimonyo, kanye nezilwane emhlabeni wonke.

Iphothifoliyo yethu ihlanganisa anhlobonhlobo ama-peptide API. Imikhiqizo ye-Flagship efana ne-Semaglutide ne-Tirzepatide igcwalise ngempumelelo ukufakwa kwe-US FDA DMF.

Inkampani yethu engaphansi, i-Hubei JXBio, isebenzisa imigqa yokukhiqiza ye-peptide API ethuthukisiwe eyakhelwe ukuhlangabezana namazinga e-cGMP avela kokubili kwe-US FDA kanye ne-NMPA yaseChina. Lesi sikhungo sihlanganisa imigqa yokukhiqiza eyi-10 emikhulu neyisivivinyo futhi isekelwa i-Quality Management System (QMS) eqinile nemithethonqubo yezempilo nokuvikeleka kwemvelo (EHS).

I-JXBio iphumelele ukuhlolwa kwe-GMP kusuka kokubili i-US FDA kanye ne-NMPA yaseChina. Siyaziqhenya ngokuqashelwa ozakwethu bomhlaba wonke bezemithi ngobuhle bekhwalithi, ukuphepha, nokuthobela imvelo.

IMIKHIQIZO EYINHLOKO

Xhumana nathi
Ngemibuzo, zizwe ukhululekile ukuxhumana nathi:
● I-Global API & Cosmetic Imibuzo:+86-150-1352-9272
● Ukubhaliswa kwe-API namasevisi e-CDMO (US & EU):+86-158-1868-2250
● I-imeyili: jymed@jymedtech.com
● Ikheli:Isitezi sesi-8 & 9, Isakhiwo soku-1, Ipaki Yezimboni Yezimboni ze-Shenzhen Biomedical Innovation, 14 Jinhui Road, IsiFunda esincane sase-Kengzi, Isifunda sase-Pingshan, e-Shenzhen, e-China.